B&K Corporation Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 2396, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest B&K Corporation news
We have not published a story on B&K Corporation yet. When there is news, it will appear here.
Questions about B&K Corporation
What is the ticker symbol of B&K Corporation?
B&K Corporation Limited trades under the ticker 2396 on HKEX.
Where is B&K Corporation listed?
B&K Corporation Limited is listed on HKEX.
Which country or territory is B&K Corporation listed under?
Our directory records B&K Corporation Limited under China.
What does B&K Corporation do?
Our directory classifies B&K Corporation Limited as: Biotechnology. This is a directory classification, not a description of the pipeline.
What is the ISIN of B&K Corporation?
The ISIN recorded for B&K Corporation Limited is CNE100007CT6.
Does aibio.space cover B&K Corporation?
aibio.space lists B&K Corporation Limited among 2,820 public biotech companies and publishes its news here as stories appear.
Which companies are similar to B&K Corporation?
Companies in our directory listed in the same country and business area as B&K Corporation: Zhuhai Trinomab Pharmaceutical Co., Shanghai RAAS Blood Products Co., Beijing Scitop Bio-Tech Co., Changchun High-Tech Industry (Group) Co., Viva Biotech Holdings, Wuhan Keqian Biology Co..
Investor discussion: B&K Corporation
Members talk about B&K Corporation (2396). Reader posts, not aibio.space reporting, and not investment advice.
Rules
Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.
Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.
Capital-markets timeline
Financings, listing notices, splits, legal actions and other investor events at B&K Corporation, newest first. Each line links the filing it comes from.
Financings
Share or debt issue: CIRCULAR OF ANNUAL GENERAL MEETING. Source
Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:2396 on TradingView.
Listing details
B&K Corporation Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 2396, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.
Published and maintained by aibio.space. Not investment advice. How we work.
Who manages this pageThis page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio